Yuichi Shinozaki

Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo

Atsuo Tanimoto, Yoshihiro Ogawa, Chika Oki et al. · Inflammation Research · 2014 · 99 citations · Full text

A novel<scp>JAK</scp>inhibitor<scp>JTE</scp>‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Atsuo Tanimoto, Yuichi Shinozaki, Yasuo Yamamoto et al. · Experimental Dermatology · 2017 · 60 citations · Full text

Ferric Citrate Hydrate, a New Phosphate Binder, Prevents the Complications of Secondary Hyperparathyroidism and Vascular Calcification

Akio Iida, Yusuke Kemmochi, Kochi Kakimoto et al. · American Journal of Nephrology · 2013 · 53 citations

Discovery of (1<i>S</i>,2<i>R</i>,3<i>R</i>)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors

Makoto Shiozaki, Katsuya Maeda, Tomoya Miura et al. · Journal of Medicinal Chemistry · 2011 · 49 citations · Full text

Aggrecanase Inhibitors, Medicinal Chemistry, Anti-inflammatory +12

JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor

Kenji Fukui, Yuichi Shinozaki, Hatsue Kobayashi et al. · European Journal of Pharmacology · 2019 · 43 citations

Inflammation, Endothelial Cell Pathobiology, Induces Erythropoiesis +11